2023 Plenary Keynote Program

WEDNESDAY, 29 NOVEMBER

08:15 Chairperson's Remarks

Allison Proffitt, Editorial Director, Bio-IT World

08:20 Welcome Remarks

Laila Cunningham, Lancaster Gate Councillor, City of Westminster

08:30 PLENARY KEYNOTE PRESENTATION: MOSAIC: A Global Initiative to Deploy At-scale Spatial Omics and Artificial Intelligence Against Cancer

Dr. Barbara Domayne-Hayman, Entrepreneur-in-Residence, Francis Crick Institute

Markus Eckstein, MD, Senior Consultant in Surgical Pathology, Institute of Pathology of FAU Medical School and University Hospital Erlangen/UKER

Raphael Gottardo, PhD, Professor and Director, Biomedical Data Science Center, Lausanne University Hospital and University of Lausanne

Joseph Lehár, PhD, Senior Vice President Business Strategy, OWKIN

In June, Owkin and world-leading Cancer research institutions and technology companies from the US, France, Germany and Switzerland unveiled MOSAIC, a $50 million initiative to use spatial omics technologies at unprecedented scale. The aim is to analyze the tumor microenvironment of more than a thousand patients in each of seven difficult to treat cancers, and to develop and apply AI/ML tools to develop a spatial omics atlas that will help to advance novel therapies. In this session, we will present the scientific vision, the aims and role of participating institutions, and an update on progress in the project's first six busy months.

10:00 Grand Opening Coffee Break in the Exhibit Hall with Poster Viewing

17:00 Chairperson's Remarks

Allison Proffitt, Editorial Director, Bio-IT World

17:05 Plenary Keynote Fireside Chat -  Data Citizenship and Changing Data Culture

Stan Gloss, Co-Founder and Fellow, BioTeam, Inc.; Podcast Host, Trends in the Trenches

Bryn Roberts, PhD, Global Head of Data & Analytics, Roche Information Solutions

With thirty years of experience in informatics and data and big pharma positions at Roche and AstraZeneca, Bryn Roberts has a unique perspective on the data-growing pains now facing life sciences. Within life sciences organizations, there are both responsibilities and privileges associated with data production and use, he says. Data producers should share data within certain parameters, and data consumers should use and credit data fairly, he believes. In this fireside chat, Stan will interview Bryn who will share his insights into the state of data right now in life sciences, why data citizenship is the paradigm shift we all need to embrace, how to truly create a FAIR data culture, and how artificial intelligence and machine learning will most impactfully change our data landscape.

17:45 Welcome Reception in the Exhibit Hall with Poster Viewing

THURSDAY, 30 NOVEMBER

09:00 Welcome by Conference Organizer

09:05 Plenary Keynote Introduction

Edward Farmer, PhD, Strategic Communications Consultant, Genomics England

09:15 Plenary Keynote Presentation:  A Global Hub for Digital Precision Medicine

Professor Sir Mark Caulfield, MD, FRCP, FESC, FPharm, FBHS, FMedSci, Vice Principal for Health, Faculty of Medicine and Dentistry, Queen Mary University of London; Director, NIHR Barts Biomedical Research Centre

Tom Chittenden, PhD, DPhil, PStat, Honorary Professor, Digital Environment Research Institute, Queen Mary University of London; CSO and President of R&D, BioAI Health

Barts Health NHS Trust and Queen Mary University of London (QMUL) are embarking on one of the world's most ambitious digital medicine initiatives. Director of the NIHR Barts Biomedical Research Centre, Prof Mark Caulfield, and newly appointed QMUL Honorary Professor Tom Chittenden will lay out this vision and its impact for patients and science. In one of the largest and most diverse NHS trusts, in the heart of the East London AI and medical research community, Barts and QMUL are investing £600m pounds to create new digital healthcare infrastructure and develop a world-leading open-access exascale causal AI computing platform. This will enable a newly detailed understanding of the biology of cancer, cardiovascular, and other diseases, driving cutting-edge drug and digital health development relevant to people of every continental ancestry. These assets will deliver the most advanced digital precision medicine to millions of people in local communities, and, through research and industry partnerships, to people and patients worldwide.

10:00 Coffee Break in the Exhibit Hall with Poster Viewing

2023 CONFERENCE PROGRAMS